EUVIMEDOpdag EUVIMED
Crossref

Exosomes derived from human dermal fibroblasts ( HDFn‐Ex ) alleviate DNCB ‐induced atopic dermatitis (AD) via PPARα

You Na Jang iD, Jung Ok Lee iD, Jung Min Lee iD, A Yeon Park iD, Yu Jin Kim iD, Su Young Kim iD, Joon Seok iD, Kwang Ho Yoo iD, Beom Joon Kim iD

Experimental Dermatology · 2024-01 · 33 (1)

DOI: 10.1111/exd.14970 ↗

At a glance

Journal article in Experimental Dermatology, published online on 2023-11-17. Written by You Na Jang and 8 co-authors. Institution: Department of Medicine, Graduate School, Chung-Ang University, Seoul, South Korea. Major MEDLINE topics: Dermatitis, Atopic, Exosomes, Skin Diseases. Cited 20 times so far (Crossref); 41 references. Funded by: Chung-Ang University Research Scholarship Grants, National Research Foundation of Korea.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Atopic dermatitis (AD) is a chronic inflammatory skin disease. Skin barrier dysfunction is the initial step in the development of AD. Recently, exosomes have been considered as potential cell‐free medicine for skin defects such as aging, psoriasis and wounds. The aim of this study was to investigate the effects of human dermal fibroblast‐neonatal‐derived exosome (HDFn‐Ex) on AD. HDFn‐Ex increased the expression of peroxisome proliferator activated receptor α (PPARα) and alleviated the 1‐chloro‐2,4‐dinitrobenzene (DNCB)‐mediated downregulation of filaggrin, involucrin, loricrin, hyaluronic acid synthase 1 (HAS1) and HAS2 in human keratinocyte HaCaT cells. However, these effects were inhibited by the PPARα antagonist GW6471. In the artificial skin model, HDFn‐Ex significantly inhibited DNCB‐induced epidermal hyperplasia and the decrease in filaggrin and HAS1 levels via a PPARα. In the DNCB‐induced AD‐like mouse model, HDFn‐Ex administration reduced epidermis thickening and mast cell infiltration into the dermis compared to DNCB treatment. Moreover, the decreases in PPARα, filaggrin and HAS1 expression, as well as the increases in IgE and IL4 levels induced by DNCB treatment were reversed by HDFn‐Ex. These effects were blocked by pre‐treatment with GW6471. Furthermore, HDFn‐Ex exhibited an anti‐inflammatory effect by inhibiting the DNCB‐induced increases in IκBα phosphorylation and TNF‐α expression. Collectively, HDFn‐Ex exhibited a protective effect on AD. Notably, these effects were regulated by PPARα. Based on our results, we suggest that HDFn‐Ex is a potential candidate for treating AD by recovering skin barrier dysfunction and exhibiting anti‐inflammatory activity.

Subjects

MeSH terms (MEDLINE)

Dermatitis, AtopicExosomesSkin DiseasesAnimalsMiceInfant, NewbornHumansPPAR alphaDinitrochlorobenzeneFilaggrin ProteinsDinitrobenzenesSkinAnti-Inflammatory AgentsCytokinesMice, Inbred BALB C

Author keywords

PPARαatopic dermatitisdermal fibroblastexosomesfilaggrinkeratinocyteskin barrier

Substances

PPAR alphaDinitrochlorobenzeneFilaggrin ProteinsDinitrobenzenesAnti-Inflammatory AgentsCytokines

Authors and institutions

  • Department of Medicine, Graduate School, Chung-Ang University, Seoul, South Korea.
  • Department of Dermatology, Chung-Ang University College of Medicine, Seoul, South Korea.
  • Department of Dermatology, Chung-Ang University Gwang-Myeong Hospital, Chung-Ang University College of Medicine, Seoul, South Korea.

ORCID profiles: You Na Jang, Jung Ok Lee, Jung Min Lee, A Yeon Park, Yu Jin Kim, Su Young Kim, Joon Seok, Kwang Ho Yoo, Beom Joon Kim

Funding

  • Chung-Ang University Research Scholarship Grants
  • National Research Foundation of Korea

Cite

APA

Jang, Y. N., Lee, J. O., Lee, J. M., Park, A. Y., Kim, Y. J., Kim, S. Y., Seok, J., Yoo, K. H., & Kim, B. J. (2024). Exosomes derived from human dermal fibroblasts ( HDFn‐Ex ) alleviate DNCB ‐induced atopic dermatitis (AD) via PPARα. Experimental Dermatology, 33(1). https://doi.org/10.1111/exd.14970

Vancouver

Jang YN, Lee JO, Lee JM, Park AY, Kim YJ, Kim SY, et al. Exosomes derived from human dermal fibroblasts ( HDFn‐Ex ) alleviate DNCB ‐induced atopic dermatitis (AD) via PPARα. Experimental Dermatology. 2024;33(1). doi:10.1111/exd.14970

BibTeX
@article{Jang2024,
  author = {Jang, You Na and Lee, Jung Ok and Lee, Jung Min and Park, A Yeon and Kim, Yu Jin and Kim, Su Young and Seok, Joon and Yoo, Kwang Ho and Kim, Beom Joon},
  title = {Exosomes derived from human dermal fibroblasts ( HDFn‐Ex ) alleviate DNCB ‐induced atopic dermatitis (AD) via PPARα},
  journal = {Experimental Dermatology},
  year = {2024},
  volume = {33},
  number = {1},
  doi = {10.1111/exd.14970}
}
Start for free →